Renal safety of zoledronic acid with thalidomide in patients with myeloma: a pharmacokinetic and safety sub-study

Spencer, Andrew; Roberts, Andrew; Kennedy, Nola; Ravera, Christina; Cremers, Serge; Bilic, Sanela; Neeman, Teresa; Copeman, Michael; Schran, Horst; Lynch, Kevin

Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Renal safety of zoledronic acid with thalidomide in patients with myeloma: a pharmacokinetic and safety sub-study

Date

2007

Authors

Spencer, Andrew

Roberts, Andrew

Kennedy, Nola

Ravera, Christina

Cremers, Serge

Bilic, Sanela

Neeman, Teresa

Copeman, Michael

Schran, Horst

Lynch, Kevin

Publisher

Blackwell Publishing Ltd

URI

http://hdl.handle.net/1885/61027

Collections

ANU Research Publications

Source

Pharmacology and Toxicology

Type

Journal article

Restricted until

2037-12-31

Downloads

File

Description

01_Spencer_Renal_safety_of_zoledronic_2007.pdf (191.03 KB)

Full item page

Cultural advice

Renal safety of zoledronic acid with thalidomide in patients with myeloma: a pharmacokinetic and safety sub-study

Date

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Description

Keywords

Citation

URI

Collections

Source

Type

Book Title

Entity type

Access Statement

License Rights

DOI

Restricted until

Downloads